Radnet (CH:PQIA)
NASDAQ:PQIA
PQIA Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
AI Platform EfficiencyDeepHealth's digital platform supports AI models that can shorten MRI scan times and increase scans per machine, boosting facility capacity and improving operating margins.
Market PositioningShift of imaging from hospitals to lower-cost outpatient centers, combined with a large multi-state RadNet network, positions the company to capture increasing scan volume and offer faster, more cost-efficient services than hospital competitors.
New Revenue StreamAI-enabled mammography has led to detection of many breast cancers and is attracting out-of-pocket payments and some payor reimbursements, creating a growing revenue stream beyond traditional imaging fees.
Bears Say
Limited New InformationAnalyst notes the report largely reiterates already disclosed information, which may limit positive market reaction due to lack of fresh catalysts.
Stock-based CompensationElevated stock-based compensation tied to development of the DeepHealth business increases reported expenses and could pressure profitability and per-share metrics until compensation levels normalize.
Radnet News
PQIA FAQ
What was Radnet’s price range in the past 12 months?
Currently, no data Available
What is Radnet’s market cap?
Radnet’s market cap is CHF3.38B.
When is Radnet’s upcoming earnings report date?
Radnet’s upcoming earnings report date is Aug 11, 2026 which is in 67 days.
How were Radnet’s earnings last quarter?
Radnet released its earnings results on May 10, 2026. The company reported -$0.221 earnings per share for the quarter, missing the consensus estimate of -$0.129 by -$0.091.
Is Radnet overvalued?
According to Wall Street analysts Radnet’s price is currently Undervalued.
Does Radnet pay dividends?
Radnet does not currently pay dividends.
What is Radnet’s EPS estimate?
Radnet’s EPS estimate is 0.15.
How many shares outstanding does Radnet have?
Currently, no data Available
What happened to Radnet’s price movement after its last earnings report?
Radnet reported an EPS of -$0.221 in its last earnings report, missing expectations of -$0.129. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Radnet?
Currently, no hedge funds are holding shares in CH:PQIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Radnet Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF67.21 (― Downside)
CHF67.21 (― Downside)
Insider Transactions
Sold Shares
Worth CHF1.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.77%
12-Months-Change
Fundamentals
Return on Equity
-1.36%
Trailing 12-Months
Asset Growth
16.46%
Trailing 12-Months
Company Description
Radnet
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
PQIA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum and financial results: record Q1 revenue and adjusted EBITDA, meaningful advanced-imaging growth, rapid ARR expansion and a robust sales pipeline in Digital Health, strategic acquisitions and healthy liquidity. Headwinds include weather-related Q1 impacts, short-term margin dilution in Digital Health from acquisitions and investments, seasonal first-quarter expense headwinds, and ongoing payer/reimbursement work for AI monetization. Overall, management raised imaging guidance, reaffirmed Digital Health guidance, and emphasized tangible productivity gains from AI deployments, indicating confidence in durable growth despite near-term investment-driven margin pressure.View all CH:PQIA earnings summariesPQIA Stock 12 Month Forecast
Average Price Target
$67.21
Options Prices
Currently, No data available
---